Literature DB >> 20427996

Prerenal azotemia in congestive heart failure.

Etienne Macedo, Ravindra Mehta.   

Abstract

Prerenal failure is used to designate a reversible form of acute renal dysfunction. However, the terminology encompasses different conditions that vary considerably. The Acute Kidney Injury Network group has recently standardized the acute kidney injury (AKI) definition and classification system; however, these criteria have not determined specific diagnostic criteria to classify prerenal conditions. The difference in the pathophysiology and manifestations of prerenal failure suggests that our current approach needs to be revaluated. Several mechanisms are recognized as contributory to development of a prerenal state associated with cardiac failure. Because of the broad differences in patients' reserve capacity and functional status, prerenal states may be triggered at different time points during the course of the disease. Prerenal state needs to be classified depending on the underlying capacity for compensation, the nature, timing of the insult and the adaptation to chronic comorbidities. Current diagnosis of prerenal conditions is relatively insensitive and would benefit from additional research to define and classify the condition. Identification of high-risk states and high-risk processes associated with the use of new biomarkers for AKI will provide new tools to distinguish between the prerenal and established AKI. Achieving a consensus definition for prerenal syndrome will allow physicians to describe treatments and interventions as well as conduct and compare epidemiological studies in order to better describe the implications of this syndrome. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20427996     DOI: 10.1159/000313723

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  5 in total

1.  Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: analysis of three randomized controlled trials.

Authors:  Jeffrey M Testani; Steven G Coca; Richard P Shannon; Stephen E Kimmel; Thomas P Cappola
Journal:  Eur J Heart Fail       Date:  2011-09-15       Impact factor: 15.534

2.  Fluid overload and changes in serum creatinine after cardiac surgery: predictors of mortality and longer intensive care stay. A prospective cohort study.

Authors:  Anna Stein; Lucas Vieira de Souza; Cassian Rodrigues Belettini; Willian Roberto Menegazzo; Júlio Rosales Viégas; Edemar Manuel Costa Pereira; Renato Eick; Lilian Araújo; Fernanda Consolim-Colombo; Maria Cláudia Irigoyen
Journal:  Crit Care       Date:  2012-05-31       Impact factor: 9.097

Review 3.  Left ventricular assist devices: a kidney's perspective.

Authors:  T R Tromp; N de Jonge; J A Joles
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

4.  The impact of cardiac resynchronization therapy on routine laboratory parameters.

Authors:  András Mihály Boros; Péter Perge; Klaudia Vivien Nagy; Astrid Apor; Zsolt Bagyura; Endre Zima; Levente Molnár; Tamás Tahin; Dávid Becker; László Gellér; Béla Merkely; Gábor Széplaki
Journal:  Interv Med Appl Sci       Date:  2017-03

5.  The Feline Cardiomyopathies: 1. General concepts.

Authors:  Mark D Kittleson; Etienne Côté
Journal:  J Feline Med Surg       Date:  2021-11       Impact factor: 2.015

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.